The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications
- 1 February 1992
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 572 (1-2) , 117-125
- https://doi.org/10.1016/0006-8993(92)90459-m
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.Journal of Clinical Investigation, 1991
- Altered Expression of Hypothalamic Neuropeptide mRNAs in Food-Restricted and Food-Deprived RatsNeuroendocrinology, 1990
- Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.Journal of Clinical Investigation, 1988
- Clinical and Biochemical Manifestations of DepressionNew England Journal of Medicine, 1988
- Clinical and Biochemical Manifestations of DepressionNew England Journal of Medicine, 1988
- Responses to Corticotropin-Releasing Hormone in the Hypercortisolism of Depression and Cushing's DiseaseNew England Journal of Medicine, 1986
- Structure of the rat pro‐opiomelanocortin (POMC) geneFEBS Letters, 1985
- Cloning and sequence analysis of cDNA for rat corticotropin‐releasing factor precursorFEBS Letters, 1985
- Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed PatientsScience, 1984
- The Corticotropin-Releasing Factor Stimulation TestNew England Journal of Medicine, 1984